• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Merck Ophthalmics

Quote




Anonymous said:
Does anyone know if they are detailing Trusopt and Cosopt?
Do they have anything else in the bag in ophthalmics? Any reps? How many?
Thanks
Click to expand...

Only Trusopt and Cosopt, nothing else. There are reps, dont think they have any counterparts. Probably about 90 nationwide. Trusopt is generally flatlined bc the class is virtually last choice as adjunctive therapy. Cosopt is growing bc doctors really like combo therapy, and this is the only one that is used mainstream (but still as adjunctive therapy). Good luck!
 




Both Cosopt and Trusopt suck! Both burn and sting, and Cosopt being part Timolol/beta blocker, there are issues w many patients such as those w Asthma, COPD, sulfa allergies etc. Both products going down hill.
 




Trusopt is flat, Cosopt is going down the drain with the arrival of Combigan (Allergan) In europe the already started to pull out of ophthalmology. Nothing in the pipeline, in a few years the ophthalmic division will be history, even in the USA.

Go for Allergan, that's the past, present and future in ophthalmology!
 




Anonymous said:
Trusopt is flat, Cosopt is going down the drain with the arrival of Combigan (Allergan) In europe the already started to pull out of ophthalmology. Nothing in the pipeline, in a few years the ophthalmic division will be history, even in the USA.

Go for Allergan, that's the past, present and future in ophthalmology!
Click to expand...

That is so much Bull** Who the hell do you think you are?? Allergan is Not the past, present, future. Combigan is a friggin joke! The doctors laugh at it. No place to put it.... Doctors are feeling that they've been lied to for years with the BS about not using a beta-blocker, all of the different %'s of Alphagan (.2, .15, .1) and bak is the worst preservative to use on the cornea. Lets get the story straight. And the COST?
 




this should be in allergan
alphagan should be three times a day and beta blockers work q am
allergan has been bad mouthing beta blockers since betagan went generic
generic beta blockers are $5 a month and so is generic alphagan
combigan is third tier
cosopt has a proven track record and will be cheap next year when it goes generic
 




damn straight, combigan sucks and it's tanking in my territory. I laugh as i see my share rise and their's stay stagnant. docs are beginning to see the redness and the BS they have been fed.
 
















































yes the group is being put back together but I just heard from a recent college grad that his friend got a job with "Merck" selling eye drops. Sounds like they are going to use a contract sales team. 100 nationwide.
 




Anonymous said:
yes the group is being put back together but I just heard from a recent college grad that his friend got a job with "Merck" selling eye drops. Sounds like they are going to use a contract sales team. 100 nationwide.
Click to expand...

What!?!? College grad? Contract sales force...oh great just what Ophthalmology needs. Pretty soon it will be.must like PC and docs won't see reps anymore. What a joke. Open it up, I know there are people who were in the old Ophthalmology group who would come back in a heartbeat if given the opp.
 




Top Bottom
Back
Quote